<DOC>
	<DOCNO>NCT00314626</DOCNO>
	<brief_summary>To evaluate proportion patient virological failure 48 week treatment combination efavirenz 600 mg + lamivudine ( 3TC ) 300 mg + abacavir 600 mg daily antiretroviral simplification regimen .</brief_summary>
	<brief_title>Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily</brief_title>
	<detailed_description>Treatment simplification therapeutic strategy allow patient control viral replication switch easier-to-take antiretroviral system promote long-term adherence thus maintain controlled viral load longer , delay evolution HIV infection . The combination ABC+3TC+EFV potent easy-to-take regimen ( 2 tablet day ) could suitable simplification antiretroviral treatment patient control viral load regimen include 2 NRTI take twice daily .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<mesh_term>Dideoxynucleosides</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>1 . Age &gt; 18 year . 2 . HIV1 infect patient . 3 . Patients HAART therapy include efavirenz two NRTIs twicedaily regimen 6 month least . 4 . Patients undetectable HIV1 viral load last 6 month ( least 2 determination separate 3 month ) . 5 . Subject able follow treatment period . 6 . Signature informed consent . 7 . Women may fertile age ( define least one year menopause undergoing surgical sterilisation technique ) , must undertake use barrier contraceptive method study . 1 . Hepatic test &gt; 5 time normality . 2 . Pregnancy breastfeed 3 . Presence opportunistic infection and/or recent tumour ( &lt; 6 month ) . 4 . Suspected documented resistance investigational drug . 5 . Known allergic hypersensitivity investigational drug similar drug . 6 . Subjects abusive consumption alcohol illegal drug . 7 . Patients participate another clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Antiviral efficacy</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Immunologic response</keyword>
	<keyword>Virologic response</keyword>
	<keyword>HIV</keyword>
</DOC>